Replies to post #337668 on Elite Pharmaceuticals Inc (ELTP)

[elichen]

I think Meshcan makes a good point about whyNas had to do the Adderrall purchase the way he did. Now it is up to Eliite investors to put pressure on Nas to transfer the rights one way or another to Elite asap! Whether through a loan of $ or sale against future profits, get them into Elite ownership so that Elite gets 100% of the profit and watch value of the pps and attractiveness to new investors and/or buyout suitors go up!

[NASDAQ2020]

I have some changes I was saving I will look over what you have done so far.
Thanks again For a great job as usual.
I will get it uploaded

NAS

[jour_trader]

I agree with the comments here. Who are Elite investors to say how Nasrat uses his personal company or cash? Because he has lent money to Elite in the past does not mean he could or would do so again. I would think for Elite to buy the Adderall rights would be much more than his prior loan to Elite. From one angle, I think it can be looked at as slimy as he will surely benefit from a sale to Elite or a packaged Elite/Mikah deal as the portfolio grows. He has benefitted in the past by selling Elite some tablescraps that allowed Elite to at least have a little cash flow while he reinvented the company.

[littlerhody]

Tripping on the pebbles, a favorite ELTP CEO pastime. We will eventually hear what really went down with this deal. In my opinion, HN had what he thought was a deal with SunGen's Ceo to take their 50% with ElTP shares. All good, except SunGen's BOD said not so fast. We do not want OTC shares, we require cash. HN went back to his folks and was told the needed cash would place a financial burden on ELTP and not to do the cash deal. HN was now between a rock and a hard place, ELTP could not do a deal but SunGen was selling their 50% come hell or high water. Obviously, HN did not want an unknown as an equal partner and was placed in a position that he had to do a deal to maintain control. Fastest and most expedient method was to step in and have Mikah do the deal. This was to put out the fire until HN had time to move the rest of his chess pieces. Short term you can scratch your head but long term I believe he has a solid strategy to bring this asset back 100% under the ELTP umbrella.
One person's theory.

[sharkey1]

Yes meshcan, I agree with everything you say. Nas took a small loan from Lincoln, my guess.

[no2koolaid]

Thanks, meshcan. How about a little more to consider?

I expect those shareholders unhappy with Nasrat and Elite about the SunGen asset acquisition by Mikah are those unhappy with the pivot away from ADF opioids. To that I say, it’s business; companies that are successful adapt and overcome obstacles and that means, sometimes, things do not turn out as planned. Show me a Fortune 100 firm and I will tell you a story about how they adapted at a critical moment.

In fact, as anyone familiar with strategy knows, it requires adaptation because situations present themselves and decisions have to be made; often on limited information. Grasping the situational context and reacting effectively is often the difference between the success or failure of a decision and an endeavor.

So it is that Elite was presented with a situation for which there was little time to make a decision. When it was determined that Elite had insufficient funds and no access to LPC, Nasrat understood that to allow SunGen’s solid dose line, that includes Adderall IR and XR, along with the potential of other drug development including generic Concerta, to be acquired by a firm that might prove a difficult partner was unacceptable; as was the potential loss of actual revenues that were now being realized and could turn the company into a notable generic drug company. The point was how to set in motion scenarios for Elite's success. Nasrat decided to use his company, Mikah, to acquire the assets and it was wise. Right now, it is likely Elite in engaged in scenario analysis to determine the best path forward. But, as should be clear when Nasrat announced that the generic Concerta would be Elite’s product, not Mikah’s, and that he hopes IR and XR will also be, that should make it clear that his focus, as Elite’s CEO, is on making the company as successful as possible. And, that his future and financial success can be much more robust with Elite being successful. All the noise that somehow Nasrat benefits more by nefarious actions is total and unmitigated BS, and completely absent an understanding of business.

THIS NOTE RESPONDS TO ANOTHER OF THE MANY MISAPPREHENSIONS OF REALITY. IT IS CAPITALIZED SO IT DOES NOT GET LOST IN READING THE POST…

THERE WAS NO LOAN FROM LPC FOR MIKAH TO DO THE ASSET ACQUISITION FROM SUNGEN…ONLY ELITE AS A COMPANY (NOT ITS CEO) WAS ABLE TO TAP INTO THE LPC FUNDING SOURCE. AND, EVEN ELITE COULD NOT DO THAT BECAUSE THE AGREEMENT SPECIFIES A TEN CENT MINIMUM P/S. AS WE KNOW AND, FOR THOSE WONDERING ABOUT THE PURPOSE OF P/S MANIPULATION, THE P/S HAS BEEN JUST BELOW THAT. OBTW: ONCE HUNAN JINGFENG (SUNGEN’S PARENT COMPANY) REJECTED THE STOCK OFFER AND ELITE COULD NOT ACCESS THE LPC FUNDING SOURCE TO COMPLETE THE SUNGEN ASSET ACQUISITION, THAT IS WHY NASRAT’S MOVE WITH MIKAH WAS A SPOT ON DECISION AND WILL ENABLE ELITE TO REALIZE THE SUCCESS THAT SHAREHOLDERS HAVE LONG BEEN WAITING FOR.

Simple, really...if you understand the business world...and I do.

N2K